Description
Reg. No. G3775 (Act 36/1947)
Namibia Reg. No. V07/24.6/56 [NS0]
INDICATIONS
Equilis® Prequenza is indicated for the active immunisation of healthy horses and ponies against equine influenza to reduce severity and duration of clinical signs and to reduce the amount and duration of viral shedding after infection.
COMPOSITION
Equilis® Prequenza is a vaccine suspension containing per 1 mℓ:
Purified haemagglutinin/neuraminidase subunits from equine influenza viruses:
– A/equine-2/ South Africa/4/03: 50 AU*
– A/equine-2/ Newmarket/2/93: 50 AU
Purified saponin (adjuvant): 375 µg
* Antigenic units
